United States · FDA National Drug Code directory
Clindamycin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-0443_33825777-3310-4c32-9f4b-3e6d12d3315d
- Product NDC
- 50090-0443
- Form
- CAPSULE
- Composition / generic term
- Clindamycin Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090826
- Source listing expiry
- 20261231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (50090-0443-0) · 50090-0443-0
- 15 CAPSULE in 1 BOTTLE (50090-0443-1) · 50090-0443-1
- 4 CAPSULE in 1 BOTTLE (50090-0443-3) · 50090-0443-3
- 100 CAPSULE in 1 BOTTLE (50090-0443-4) · 50090-0443-4
- 21 CAPSULE in 1 BOTTLE (50090-0443-6) · 50090-0443-6
- 42 CAPSULE in 1 BOTTLE (50090-0443-7) · 50090-0443-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →